Navigation Links
China Biologic Products Reports First Quarter 2008 Results
Date:5/15/2008

nts of $1,281,172

and $1,238,772 as of March 31, 2008 and 1,311,347 316,869

December 31, 2007, respectively

Notes receivable 42,840 41,130

Other receivables 441,526 425,163

Other receivable- related party 300,948 290,307

Inventories 11,520,085 9,505,074

Prepayments and deferred expense 243,073 138,756

Total current assets 19,012,448 15,727,332

PLANT AND EQUIPMENT, net 17,072,037 15,434,124

OTHER ASSETS:

Prepayments-non-current 850,130 711,459

Long term prepayment - related party 537,928 516,456

Intangible assets, net 930,584 915,874

Total other assets 2,318,642 2,143,789

Total assets $ 38,403,127 $ 33,305,245

L I A B I L I T I E S A N D S H A R E H O L D E R S' E Q U I T Y

CURRENT LIABILITIES:

Accounts payable $ 2,471,482 $ 2,677,587

Short term loans - bank 685,500

Short term loan - minority shareholder 752,720 722,674

Other payables and accrued liabilities 1,353,242 1,200,068

Other payable - land use right 317,896 305,571

Dividend payable 915,762 506,626

Customer deposits 1,362,936 398,794

Taxes payable 1,291,653 384,788

Total current liabilities 8,465,691 6,881,608

COMMITMENT AND CONTINGENCIES 40,030
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD) ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... for trading in the United States ... to commence on September 17, 2014 on the OTCQX ... trade on the TSX Venture Exchange under its existing ...
(Date:9/17/2014)... MARLBOROUGH, Mass. , Sept. 17, 2014 /PRNewswire/ ... ), a biotechnology company focused on discovering, developing ... needs using RNA-targeted technologies, today announced that it has ... Patent and Trademark Office on its unique delivery ... ® ) to phagocytic cells for the treatment ...
(Date:9/17/2014)... September 17, 2014 Beckman Coulter ... science and healthcare, has renewed its agreement with ... part of the agreement, Personify will continue to streamline ... emphasis on recruitment analytics, including time-to-fill, time-to-source and a ... our agreement with Personify was based on the success ...
(Date:9/17/2014)... 17, 2014 First ... from a truly novel class of anti-infective ... Biopharma, a biopharmaceutical company developing a truly ... it has secured £4.0m ($6.4m) to advance ... against a range of Gram-positive infections including  ...
Breaking Biology Technology:SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 2SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 3RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 2RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 3RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 4Beckman Coulter Signs 3-year RPO Contract with Personify 2Beckman Coulter Signs 3-year RPO Contract with Personify 3MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 2MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 3MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 4MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 5MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 6MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 7
...  Rhythm announced today that Lex Van der Ploeg, PhD, ... Van der Ploeg brings to Rhythm more than 25 ... and other therapeutic areas. "Lex has considerable ... pathways we are targeting with our ghrelin and melanocortin ...
... for Nanotechnology (LCN) have discovered electronic stripes, called ,charge ... that make up a graphitic superconductor. This is the ... and the finding is likely to have profound implications ... scientists believe will play a key role in the ...
... /PRNewswire-iReach/ --  Quantum Leap Innovations announced today the ... Directors.  Michael Cusumano is the Sloan Management Review Distinguished ... Sloan School of Management, with a joint appointment in ... STAYING POWER , covers six enduring principles for ...
Cached Biology Technology:Rhythm Names Lex Van der Ploeg Chief Scientific Officer 2Graphene earns its stripes 2Michael Cusumano, MIT's Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors 2Michael Cusumano, MIT's Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors 3Michael Cusumano, MIT's Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors 4
(Date:9/16/2014)... to Spain culminating the around the world of the ... how the global ocean works and what is its ... atmosphere is not limited to coastal areas, but also ... and it is already affecting the ocean ecosystem. ,This ... Residence for Researchers in Barcelona, in a congress that ...
(Date:9/16/2014)... 16, 2014 Schizophrenia is associated with increased rates ... of research suggests that the relationship between schizophrenia and ... to use nicotine to self-medicate symptoms and cognitive impairment ... in the current issue of Biological Psychiatry , ... the level of nicotine receptors in the brain was ...
(Date:9/16/2014)... choices such as buying clothing not made in a ... bringing their own bags when they go shopping? According ... Consumer Research , ethical consumption is motivated by a ... practices into action. , "Advocates of ethical consumerism suggest ... of the products they choose, but unfortunately only a ...
Breaking Biology News(10 mins):The Malaspina Expedition confirms that pollution reaches even the most remote areas of the ocean 2The Malaspina Expedition confirms that pollution reaches even the most remote areas of the ocean 3Smoking and schizophrenia linked by alterations in brain nicotine signals 2Why are consumers willing to spend more money on ethical products? 2
... Research Hospital investigators have identified a novel structure in cells ... for eliminating damaged cells and also offers new therapeutic potential. ... work as cells ramp up production of p53 protein following ... how cells respond to the stress that damages DNA. The ...
... is available in Spanish . , A ... cooperators provides new details about how fertilizing soils with ... other cleaning suppliesinto the environment. Farmers add "Class ... their fields as a fertilizer. These biosolids meet federal ...
... Friday, Sept. 9, 2010 -- Keynote speakers have ... set for Dec. 5-8 at the Hilton in the ... conference theme is "Where Discovery Meets Innovation." The ... America conference will cover a wide range of topics ...
Cached Biology News:New insights provide promise for development of tools to protect damaged tissues 2New insights provide promise for development of tools to protect damaged tissues 3Tracking triclosan's field footprint 2
Mouse polyclonal antibody raised against a partial recombinant KCTD13. NCBI Entrez Gene ID = 253980...
... direct antibiotic-based selection system for recombinant identification. ... eliminating the need for costly color screening. ... to 100% accuracy in recombinant selection. pLivSelect ... colony picking. This cloning kit is ...
Alpha-2-antiplasmin precursor (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Alpha-2-AP). [Source:Uniprot/SWISSPROT;Acc:P08697] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
Biology Products: